GB9314973D0 - Medicaments - Google Patents

Medicaments

Info

Publication number: GB9314973D0
Authority: GB; United Kingdom
Prior art keywords: medicaments
Prior art date: 1993-07-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GB939314973A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Ltd

Original Assignee

SmithKline Beecham Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-20

Filing date

1993-07-20

Publication date

1993-09-01

1993-07-20 Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd

1993-07-20 Priority to GB939314973A priority Critical patent/GB9314973D0/en

1993-09-01 Publication of GB9314973D0 publication Critical patent/GB9314973D0/en

1994-07-11 Priority to PCT/EP1994/002298 priority patent/WO1995003302A1/en

1994-07-11 Priority to JP7504909A priority patent/JPH09500383A/en

1994-07-11 Priority to AU73858/94A priority patent/AU7385894A/en

1994-07-11 Priority to EP94923730A priority patent/EP0710237A1/en

1994-07-18 Priority to ZA945237A priority patent/ZA945237B/en

Status Pending legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems

GB939314973A 1993-07-20 1993-07-20 Medicaments Pending GB9314973D0 (en)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
GB939314973A GB9314973D0 (en)	1993-07-20	1993-07-20	Medicaments
PCT/EP1994/002298 WO1995003302A1 (en)	1993-07-20	1994-07-11	Quinolizidines with calcium channel antagonistic activity
JP7504909A JPH09500383A (en)	1993-07-20	1994-07-11	Quinolizidine having calcium channel antagonist activity
AU73858/94A AU7385894A (en)	1993-07-20	1994-07-11	Quinolizidines with calcium channel antagonistic activity
EP94923730A EP0710237A1 (en)	1993-07-20	1994-07-11	Quinolizidines with calcium channel antagonistic activity
ZA945237A ZA945237B (en)	1993-07-20	1994-07-18	Azabicyclic dericatives

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB939314973A GB9314973D0 (en)	1993-07-20	1993-07-20	Medicaments

Publications (1)

Publication Number	Publication Date
GB9314973D0 true GB9314973D0 (en)	1993-09-01

Family

ID=10739088

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB939314973A Pending GB9314973D0 (en)	1993-07-20	1993-07-20	Medicaments

Country Status (6)

Country	Link
EP (1)	EP0710237A1 (en)
JP (1)	JPH09500383A (en)
AU (1)	AU7385894A (en)
GB (1)	GB9314973D0 (en)
WO (1)	WO1995003302A1 (en)
ZA (1)	ZA945237B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0839898A1 (en)	1996-11-04	1998-05-06	The Procter & Gamble Company	Self-thickened cleaning compositions
EP1200440A1 (en) *	1999-07-06	2002-05-02	Vertex Pharmaceuticals Incorporated	Quinuclidine derivatives for treatment of neurological disorders
CA2422055A1 (en)	2000-09-11	2002-03-21	Sepracor, Inc.	Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
US7294637B2 (en)	2000-09-11	2007-11-13	Sepracor, Inc.	Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
GB0229822D0 (en) *	2002-12-20	2003-01-29	Glaxo Group Ltd	Novel compounds
US7655657B2 (en)	2003-12-22	2010-02-02	Abbott Laboratories	Fused bicycloheterocycle substituted quinuclidine derivatives
US7241773B2 (en)	2003-12-22	2007-07-10	Abbott Laboratories	3-quinuclidinyl heteroatom bridged biaryl derivatives
US7309699B2 (en)	2003-12-22	2007-12-18	Abbott Laboratories	3-Quinuclidinyl amino-substituted biaryl derivatives
US7160876B2 (en)	2003-12-22	2007-01-09	Abbott Laboratories	Fused bicycloheterocycle substituted quinuclidine derivatives
DE102004039789A1 (en)	2004-08-16	2006-03-02	Sanofi-Aventis Deutschland Gmbh	Aryl-substituted polycyclic amines, process for their preparation and their use as pharmaceuticals

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4689329A (en) *	1986-02-04	1987-08-25	Mcneilab, Inc.	5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
US4716172A (en) *	1986-04-10	1987-12-29	Mcneilab, Inc.	4-substituted octahydroquinolizine analgesic compounds and octahydroquinolizinium intermediates
JPS63122682A (en) *	1986-11-13	1988-05-26	Shinichiro Sakai	Indoloquinolizidine derivative
NZ227841A (en) *	1988-02-12	1991-08-27	Merck Sharp & Dohme	Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
IE912759A1 (en) *	1990-08-06	1992-02-12	Smith Kline French Lab	Compounds
MX9100517A (en) *	1990-08-06	1992-04-01	Smith Kline French Lab	COMPOUNDS
GB9113031D0 (en) *	1991-06-17	1991-08-07	Smithkline Beecham Plc	Compounds
JPH06509574A (en) *	1991-08-03	1994-10-27	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	5-HT↓4 receptor antagonist
CA2118798A1 (en) *	1991-09-12	1993-03-18	Francis D. King	Azabicyclic compounds as 5-ht4 receptor antagonists
EP0609278A1 (en) *	1991-10-24	1994-08-10	Smithkline Beecham Plc	Imidazopyridines and indolizines as 5-ht 4 antagonists
WO1993015052A1 (en) *	1992-01-28	1993-08-05	Smithkline Beecham Plc	Compounds as calcium channel antagonists
GB9201749D0 (en) *	1992-01-28	1992-03-11	Smithkline Beecham Plc	Medicaments
GB9201751D0 (en) *	1992-01-28	1992-03-11	Smithkline Beecham Plc	Compounds
GB9226111D0 (en) *	1992-12-15	1993-02-10	Smithkline Beecham Plc	Madicaments

1993
- 1993-07-20 GB GB939314973A patent/GB9314973D0/en active Pending
1994
- 1994-07-11 AU AU73858/94A patent/AU7385894A/en not_active Abandoned
- 1994-07-11 JP JP7504909A patent/JPH09500383A/en active Pending
- 1994-07-11 WO PCT/EP1994/002298 patent/WO1995003302A1/en not_active Application Discontinuation
- 1994-07-11 EP EP94923730A patent/EP0710237A1/en not_active Withdrawn
- 1994-07-18 ZA ZA945237A patent/ZA945237B/en unknown

Also Published As

Publication number	Publication date
ZA945237B (en)	1996-01-18
JPH09500383A (en)	1997-01-14
AU7385894A (en)	1995-02-20
EP0710237A1 (en)	1996-05-08
WO1995003302A1 (en)	1995-02-02

Publication	Publication Date	Title
GB9308430D0 (en)	1993-06-09	Medicaments
HU9402301D0 (en)	1994-10-28	Medicaments
AP9700951A0 (en)	1997-04-30	Medicaments
GB9201749D0 (en)	1992-03-11	Medicaments
ZA935522B (en)	1994-06-13	Medicaments
GB9315566D0 (en)	1993-09-08	Medicaments
GB9313574D0 (en)	1993-08-18	Medicaments
GB9314973D0 (en)	1993-09-01	Medicaments
GB9224739D0 (en)	1993-01-13	Medicaments
GB9202522D0 (en)	1992-03-25	Medicaments
GB9313649D0 (en)	1993-08-18	Medicaments
GB9325335D0 (en)	1994-02-16	Medicaments
GB9304010D0 (en)	1993-04-14	Medicaments
GB9303188D0 (en)	1993-03-31	Medicaments
GB9321194D0 (en)	1993-12-01	Medicaments
GB9304021D0 (en)	1993-04-14	Medicaments
GB9201404D0 (en)	1992-03-11	Medicaments
GB9205139D0 (en)	1992-04-22	Medicaments
GB9201414D0 (en)	1992-03-11	Medicaments
GB9201359D0 (en)	1992-03-11	Medicaments
GB9201484D0 (en)	1992-03-11	Medicaments
GB9225684D0 (en)	1993-02-03	Medicaments
ZA935477B (en)	1994-02-23	Medicaments
GB9210306D0 (en)	1992-07-01	Medicaments
GB9216857D0 (en)	1992-09-23	Medicaments